Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.
D000284:Administration, Oral; D000368:Aged; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004296:Dopa Decarboxylase / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D007697:Kinesics; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009949:Orientation / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D013268:Stimulation, Chemical
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine; D004296:Dopa Decarboxylase